Digoxin use is associated with pancreatic cancer risk but does not affect survival.
Saved in:
| Title: | Digoxin use is associated with pancreatic cancer risk but does not affect survival. |
|---|---|
| Authors: | Boursi B; Division of Gastroenterology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. ben.boursi@sheba.health.gov.il.; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. ben.boursi@sheba.health.gov.il.; Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. ben.boursi@sheba.health.gov.il.; Tel-Aviv University, Tel-Aviv, Israel. ben.boursi@sheba.health.gov.il.; Department of Oncology, Sheba Medical Center, Tel-Hashomer, Israel. ben.boursi@sheba.health.gov.il., Huber JS; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Haynes K; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Mamtani R; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Yang YX; Division of Gastroenterology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. |
| Source: | Cancer causes & control : CCC [Cancer Causes Control] 2021 Jan; Vol. 32 (1), pp. 41-46. Date of Electronic Publication: 2020 Oct 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 9100846 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7225 (Electronic) Linking ISSN: 09575243 NLM ISO Abbreviation: Cancer Causes Control Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
